Baxter Protein Manufacturing Capacity

Plasma

Recombinant

Vaccines

~$2 Billion Cumulative Investment in Manufacturing Capacity from 1995 to 2005

• Krems

• Maryland

• Orth

• Prague

• Acambis

• Lessines

• Los Angeles

• Rieti

• Rochester

• Vienna

• Boulder

• Hayward

• Neuchatel

• Orth

• Thousand Oaks

Previous slide

Next slide

Back to first slide

View graphic version